Perioperative Insulin Pump Therapy Decreases Readmission Risk and Improves Outcomes in Patients with Diabetes
Experimental and Clinical Endocrinology & Diabetes · 01.03.2024 · 132 (03) · 142-151
DOI: 10.1055/a-2218-4574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.03.2024. Verfasst von Kun Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Hainan Medical University, Hainan Clinical Research Center for Metabolic Disease, Haikou, Hainan, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1. Die Arbeit nennt 30 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
To evaluate the impact of temporary insulin pump use during hospitalization on glycemia, postoperative complications, and cost/utilization in perioperative patients with diabetes.
Methods
Patients (n=159) with type 2 diabetes and hospitalized for elective surgery were recruited from three hospitals. Subjects were categorized into the insulin pump group and the multiple daily subcutaneous insulin injection group according to their treatment therapy. Data were collected at admission, discharge, and 3 months post-discharge.
Results
Subjects in the CSII group who were still on insulin therapy transitioned from CSII to MDII; however, their daily insulin dosages were lower than those in the MDII group (15.31±10.98 U/d vs. 23.48±17.02 U/d, P=0.015) after discharge. In terms of medical costs, the CSII group had significantly higher hospitalization costs than the MDII group (112.36±103.43 thousand RMB vs. 82.65±77.98 thousand RMB, P=0.043). After 3 months, the CSII group had significantly lower outpatient costs than the MDII group (3.17±0.94 thousand RMB vs. 3.98±1.76 thousand RMB, P ˂ 0.001). In the MDII group, 10 patients reported severe postoperative complications requiring re-hospitalization; there were no similar reports in the CSII group.
Conclusion
Temporary use of insulin pump therapy for perioperative patients with diabetes results in a reduction in blood glucose and blood glucose fluctuation during hospitalization, HbA1c, and the risk of postoperative complication and readmission, thus significantly decreasing costs in this complex patient cohort. Further work is needed to better understand indications for utilizing pump therapy based on diabetes phenotype and the complexity of planned surgical intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Hainan Medical University, Hainan Clinical Research Center for Metabolic Disease, Haikou, Hainan, China.
- Nursing College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China.
- Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, USA.
- Jiangsu College of Nursing, Huaian, Jiangsu, China.
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China.
ORCID-Profile: Qingqing Lou
Zitieren
APA
Wang, K., Bai, F., Chen, X., Miller, J. D., Chen, X., Yun, C., Sun, Z., Yuan, X., & Lou, Q. (2024). Perioperative Insulin Pump Therapy Decreases Readmission Risk and Improves Outcomes in Patients with Diabetes. Experimental and Clinical Endocrinology & Diabetes, 132(03), 142-151. https://doi.org/10.1055/a-2218-4574
Vancouver
Wang K, Bai F, Chen X, Miller JD, Chen X, Yun C, et al. Perioperative Insulin Pump Therapy Decreases Readmission Risk and Improves Outcomes in Patients with Diabetes. Experimental and Clinical Endocrinology & Diabetes. 2024;132(03):142-151. doi:10.1055/a-2218-4574
BibTeX
@article{Wang2024,
author = {Wang, Kun and Bai, Fang and Chen, Xiaopan and Miller, Joshua D and Chen, Xue and Yun, Chuan and Sun, Zhenzhen and Yuan, Xiaodan and Lou, Qingqing},
title = {Perioperative Insulin Pump Therapy Decreases Readmission Risk and Improves Outcomes in Patients with Diabetes},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2024},
volume = {132},
number = {03},
pages = {142--151},
doi = {10.1055/a-2218-4574}
}
EUVIMED